Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
- 2020年07月09日 03:30:00
- テクノロジー
- JCN Newswire
According to Frost &Sullivan:
"The Frost &Sullivan Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry to identify best practices."
Avance Clinical CEO Yvonne Lungershausen:
Commending her team of more than 100 clinical trial specialists throughout Australia and New Zealand, "We have shown, with our repeat business rate greater than 75%, that our consistent sponsor focussed culture and nimble proactive approach wins every time. This has been recognised by the research team at Frost &Sullivan and the entire Avance Clinical team are very proud.
"Australia, which has successfully managed the COVID-19 crisis, is open for business for clinical trials. This award further reinforces to the biotech community that this is an early phase specialist destination where they can turn around delayed trials. Avance Clinical are experts in facilitating fast study startup with trials typically approved and initiated in under 6 weeks."
Avance Clinical has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years. Avance specialises in supporting biotech companies with their early phase clinical trials, having conducted over 150 early phase (Phase 1 &2) trials in the past 4 years, involving the treatment of 8,300 participants across 95 therapeutic indications.
According to Nidhi Jalali, Analyst Best Practices, Frost &Sullivan:
"Within Asia-Pacific's highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials. Avance's reputation for high-quality clinical trial outcomes has attracted an impressive 74% repeat business rate, underscoring the company's position as a market leader.
Avance Clinical offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. The company has grown quickly over the past year doubling staff numbers, with plans to further expand. Avance Clinical offers a real size match for biotechs, meaning better mission understandings and stronger customer service compared to the larger CROs."
In addition to the impressive COVID-19 management in Australia, a key factor in sponsor demand is the speed, access to high-quality sites and attractive cost of running trials in Australia including:
- The Australian Government financial rebate of up to 43.5% on clinical trial spend
- No IND required for clinical trials and streamlined regulatory processes
- Advanced medical, research and scientific community, leading investigators &KOLs, modern medical facilities
Australia's reputation for FDA compliant scientific and research excellence, its advanced healthcare, and the opportunity to access patients in a less clinical trial competitive environment further reinforces its advantage as a destination for clinical trials.
Learn about running your next study with Avance Clinical: https://www.avancecro.com/.
About the Frost &Sullivan Awards
The Frost &Sullivan 2020 Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry in order to identify best practices.
With a strong overall performance, Avance Clinical earns the 2020 Asia-Pacific CRO Market Leadership Award. We also recognize that your receipt of this award is the result of many individuals (employees, customers and investors) making daily choices to believe in the organization and contribute in a meaningful way to its future.
About Avance Clinical
Australia's Avance Clinical Pty Ltd has more than 20-years of experience and is now one of Australia's leading Contract Research Organisations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialised patient groups. Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. Telehealth pivot during COVID-19 pandemic - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. An established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialised patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with long track records in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round taking advantage of Australia's counter-flu and allergy seasons
Media Contact:
media@avancecro.com
Chris Thompson
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
マンション刺殺、被害者は19歳大学生の女性 大阪・枚方
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
「どきたくないニャ!」お布団からどかされる気配に気付いた猫さんが話題「察知能力すごい」
【阪神】及川雅貴が24日巨人戦先発へ 巨人打線は「左ばっかり」岡田監督、青柳抹消で白羽
【日本ハム】救援失敗の斎藤友貴哉2軍再調整決定 新庄監督「真っすぐを磨きに行ってもらって」
【5月19日生まれの著名人】芹那、ハライチ澤部佑、神木隆之介、永島聖羅ら
ザ・パンチが芸風を変えて大ウケ!「THE SECOND」に続き「大江裕」もトレンド入り
葉月あや、三角ビキニで大迫力のたわわGカップを披露!フィリピン滞在中のオフショットを公開
【THE SECOND】2代目王者はガクテンソク「漫才辞めません!」大会史上最高得点でV
大会史上最高得点2代目王者ガクテンソク かつて解散考えた“ターニングポイント”明かす
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
大谷翔平が不運な判定で2度見逃し三振 「えん罪退場」で話題の球審は引き揚げる大谷にブチギレ
ヒカル、浮気相手とのLINE流出にドン引きの声「キモすぎる」「吐きそう」
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
吉野家が「マスク外し強要疑惑」でプチ炎上、店員さんに聞いてみると……
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
時代劇の常識を覆す!仇討ち・無礼討ちの厳格なルール
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
藤田ニコル「脱ぐ予定なかったのですが気づいたらノリノリで…」ヒョウ柄水着姿に大反響
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
ヒカル、浮気相手とのLINE流出にドン引きの声「キモすぎる」「吐きそう」
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
大谷翔平が不運な判定で2度見逃し三振 「えん罪退場」で話題の球審は引き揚げる大谷にブチギレ
完全にダマされた! 『ラヴィット!』あのちゃん“事故レベル”大暴走は『水ダウ』遠隔操作のしわざだった ネットも納得
73歳神田正輝「旅サラダ」生放送で“12歳下俳優”から呼び捨てされ激論
マンション刺殺、被害者は19歳大学生の女性 大阪・枚方
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
「どきたくないニャ!」お布団からどかされる気配に気付いた猫さんが話題「察知能力すごい」
【阪神】及川雅貴が24日巨人戦先発へ 巨人打線は「左ばっかり」岡田監督、青柳抹消で白羽
【5月19日生まれの著名人】芹那、ハライチ澤部佑、神木隆之介、永島聖羅ら
【日本ハム】救援失敗の斎藤友貴哉2軍再調整決定 新庄監督「真っすぐを磨きに行ってもらって」
葉月あや、三角ビキニで大迫力のたわわGカップを披露!フィリピン滞在中のオフショットを公開
ザ・パンチが芸風を変えて大ウケ!「THE SECOND」に続き「大江裕」もトレンド入り
【THE SECOND】2代目王者はガクテンソク「漫才辞めません!」大会史上最高得点でV
大会史上最高得点2代目王者ガクテンソク かつて解散考えた“ターニングポイント”明かす